Correlation Between Oncorus and Neximmune

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncorus and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Neximmune, you can compare the effects of market volatilities on Oncorus and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Neximmune.

Diversification Opportunities for Oncorus and Neximmune

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Oncorus and Neximmune is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Oncorus i.e., Oncorus and Neximmune go up and down completely randomly.

Pair Corralation between Oncorus and Neximmune

Given the investment horizon of 90 days Oncorus is expected to under-perform the Neximmune. But the stock apears to be less risky and, when comparing its historical volatility, Oncorus is 1.32 times less risky than Neximmune. The stock trades about -0.14 of its potential returns per unit of risk. The Neximmune is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,050  in Neximmune on August 27, 2024 and sell it today you would lose (807.00) from holding Neximmune or give up 76.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy26.45%
ValuesDaily Returns

Oncorus  vs.  Neximmune

 Performance 
       Timeline  
Oncorus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Neximmune 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Oncorus and Neximmune Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncorus and Neximmune

The main advantage of trading using opposite Oncorus and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.
The idea behind Oncorus and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital